Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirofiban in Acute Ischemic Stroke Patients Treated With Mechanical Thrombectomy
NCT04851457Phase 2Completed
- Sponsor
- Shanghai East Hospital
- Start
- Apr 2021
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tirofiban in acute ischemic stroke (AIS) (2 arms), sponsored by Shanghai East Hospital. Primary endpoint: Composite rates of target vessel revascularization and no symptomatic intracerebral haemorrhage. Started Apr 2021; status: completed.
02
Drugs
tirofiban
03
Conditions
acute ischemic stroke (AIS)
Beyond the preview
Go deeper on NCT04851457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04851457.